STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS

被引：0
|
作者：
Lagerwaard, Frank J. [1 ]
Verstegen, Naomi E. [1 ]
Haasbeek, Cornelis J. [1 ]
Slotman, Ben [1 ]
Paul, M. A. [2 ]
Smit, Egbert F. [3 ]
Senan, Suresh [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Thorac Surg, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, Amsterdam, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Stage I non-small cell lung cancer; Operable; Stereotactic ablative radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S278 / S279
页数：2
相关论文
共 50 条
  • [21] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
    Beltramo, G.
    Bergantin, A.
    Martinotti, A.
    Bonfanti, P.
    Bianchi, L. C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571
  • [22] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
    White, Abby
    Swanson, Scott J.
    JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
  • [23] Stereotactic radiotherapy in stage I non-small cell lung cancer
    Fleckenstein, J.
    Ruebe, C.
    ONKOLOGE, 2018, 24 (12): : 967 - 973
  • [24] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
    Aerts, Joachim G.
    De Goeje, Pauline
    Schram, Merel
    Bezemer, Koen
    Kaijen-Lambers, Margaretha
    Hegmans, Joost
    De langen, Joop
    Maat, Alexander
    Nuyttens, Joost
    Hendriks, Rudi
    Smit, Egbert
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
  • [25] Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)
    Pickles, R. L.
    Iqbal, S.
    Atherton, P.
    Turnbull, H.
    Mcmenemin, R.
    Walker, C.
    Pilling, K.
    Muller, M.
    Mott, J.
    Mccallum, H.
    LUNG CANCER, 2016, 91 : S47 - S48
  • [26] Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study
    Beal, J.
    Gomes, D.
    Taranto, P.
    Koch, L.
    Rezende, A. C.
    Samano, M.
    Bibas, B.
    Gomes, O.
    Campregher, P.
    Severino, P.
    Marti, L.
    Paes, V.
    Chate, R.
    Sales, D.
    Schvartsman, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S651 - S652
  • [27] Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study
    Schvartsman, G.
    Amarato, Y.
    dos Santos, G. Prado
    Gomes, D. Bugano Diniz
    Koch, L. D. O.
    Bibas, B.
    Gomes, O., Jr.
    Campregher, P. Vidal
    Severino, P.
    Marti, L. Cavalheiro
    Ribeiro, V. Paes
    Leaden, L.
    Chate, R. Caruso
    de Campos, J. Ribas Milanez
    Sousa, V. A. Ramos
    Taranto, P.
    Moura, F. S.
    Terra, R. M.
    Rezende, A. C. P. D.
    Samano, M. Naoyuki
    ANNALS OF ONCOLOGY, 2024, 35 : S785 - S785
  • [28] Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    de Ruiter, Julianne Cynthia
    van Diessen, Judi Nani Annet
    Smit, Egbert Frederik
    van der Noort, Vincent
    Damhuis, Ronald Alphons Maria
    Hartemink, Koen Johan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (03)
  • [29] Long-term outcomes of Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer
    Lee, S.
    Song, S. Y.
    Kim, S. S.
    Lee, S. W.
    Ahn, S. D.
    Yoon, S. M.
    Kim, Y. S.
    Park, J. H.
    Kim, J. H.
    Choi, E. K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S655 - S655
  • [30] Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review
    Wang, Siwei
    Wang, Xiaoxiao
    Zhou, Qing
    Xu, Youtao
    Xia, Wenjia
    Xu, Weizhang
    Ma, ZhiFei
    Qiu, Mantang
    You, Ran
    Xu, Lin
    Yin, Rong
    THORACIC CANCER, 2018, 9 (03) : 337 - 347
12345